Brazil's Anvisa authorizes oral semaglutide of Wegovy for obesity and overweight

Brazil's health regulator Anvisa authorized the oral semaglutide of Wegovy for the treatment of obesity and overweight, according to Folha.

Detected & updated continuously · Source: Nebula